Market closed

Orchestra BioMed Holdings, Inc./$OBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Ticker

$OBIO
Trading on

Industry

Health Care Equipment & Supplies

Employees

70

OBIO Metrics

BasicAdvanced
$106M
-
-$1.66
0.59
-
$106M
0.59
$5.04
$2.65
4.268
4.128
48.483
50.152
-216.50%
-46.90%
-120.84%
38.524
3.2
3.2
-1.999
-4.42%
12.10%
49.98%
-46.63%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OBIO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Orchestra BioMed Holdings, Inc. stock?

Orchestra BioMed Holdings, Inc. (OBIO) has a market cap of $106M as of April 05, 2025.

What is the P/E ratio for Orchestra BioMed Holdings, Inc. stock?

The price to earnings (P/E) ratio for Orchestra BioMed Holdings, Inc. (OBIO) stock is 0 as of April 05, 2025.

Does Orchestra BioMed Holdings, Inc. stock pay dividends?

No, Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Orchestra BioMed Holdings, Inc. dividend payment date?

Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Orchestra BioMed Holdings, Inc.?

Orchestra BioMed Holdings, Inc. (OBIO) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.